Showing results (211-220 of 320) with videos related to
Sort By:
Pageof 32
Journal of Neuropathology and Experimental Neurology|December 23, 1998
Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individualsC M Hulette, K A Welsh-Bohmer, M G Murray, et al.Parkinsonism & Related Disorders|August 10, 2015
Deficient vesicular storage: A common theme in catecholaminergic neurodegenerationDavid S Goldstein, Courtney Holmes, Patti Sullivan, et al.Investigative Ophthalmology & Visual Science|September 1, 1990
Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trialV Dobson, G E Quinn, A W Biglan, et al.Ophthalmology|September 1, 1996
Visual fields measured with double-arc perimetry in eyes with threshold retinopathy of prematurity from the cryotherapy for retinopathy of prematurity trial. The CRYO-Retinopathy of Prematurity Cooperative GroupG E Quinn, V Dobson, R J Hardy, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|September 1, 1996
Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative GroupW S Gilbert, G E Quinn, V Dobson, et al.Lipids|January 1, 1997
Visual acuity and blood lipids in term infants fed human milk or formulaeS M Innis, S S Akrabawi, D A Diersen-Schade, et al.Restorative Neurology and Neuroscience|November 12, 2016
Cocaine promotes primary human astrocyte proliferation via JNK-dependent up-regulation of cyclin A2Chun-Ting Lee, Kristen L Boeshore, Chun Wu, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|August 1, 1993
Prediction of visual function in eyes with mild to moderate posterior pole residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative GroupJ Reynolds, V Dobson, G E Quinn, et al.Annals of the New York Academy of Sciences|November 2, 2017
Medication Development of Ibogaine as a Pharmacotherapy for Drug DependenceaDeborah C Mash, Craig A Kovera, Billy E Buck, et al.Annals of the New York Academy of Sciences|July 21, 1998
Medication development of ibogaine as a pharmacotherapy for drug dependenceD C Mash, C A Kovera, B E Buck, et al.Pageof 32